BHMT2

BHMT2 is a mammalian zinc metalloenzyme of hepatic and renal one-carbon metabolism that remethylates homocysteine to methionine, using S-methylmethionine (SMM) rather than betaine as its methyl donor — a substrate specificity that distinguishes it from its paralog BHMT (PMID:18230605, PMID:11087663). Kinetic characterization of purified recombinant enzyme established an SMM Km of ~0.94 mM with turnover comparable to BHMT, and a distinct inhibitor profile in which methionine is a strong inhibitor and S-adenosylmethionine a weak one, while betaine and dimethylglycine do not inhibit (PMID:18230605). The protein is intrinsically unstable in mammalian cells and is stabilized through direct physical interaction with BHMT, with which it co-precipitates (PMID:18457970). Through its SMM-dependent contribution to methionine and downstream glutathione biosynthesis, BHMT2 protects against acetaminophen-induced hepatotoxicity in a diet-dependent manner, since SMM is supplied only by plant sources (PMID:19923254). Beyond classical one-carbon metabolism, BHMT2 feeds S-adenosylmethionine production and histone methylation: acting with MAT1A in intestinal epithelial cells, it regulates AHSG expression and drives M1 macrophage activation and inflammatory cytokine output (PMID:41219226).

1. 2000 Medium

   Before its biochemistry was known, the question was whether the BHMT-like gene encoded a distinct, tissue-restricted enzyme; cloning defined a 363-residue protein highly similar to BHMT but expressed predominantly in liver and kidney.

   Evidence cDNA cloning, physical mapping and Northern expression profiling of human BHMT2

   PMID:11087663

   Open questions at the time

   • No catalytic activity or substrate demonstrated
   • Subcellular localization not established
2. 2008 High

   The central mechanistic question — what reaction BHMT2 catalyzes — was answered by showing it is a zinc metalloenzyme that remethylates homocysteine using SMM, not betaine, defining its functional divergence from BHMT.

   Evidence In vitro enzymatic assay with purified recombinant enzyme, kinetic and inhibitor profiling

   PMID:18230605

   Open questions at the time

   • No crystal structure or catalytic-mechanism model
   • Physiological flux through the SMM pathway in vivo not quantified in this study
3. 2008 Medium

   Why BHMT2 protein is hard to express was addressed by showing it is rapidly degraded but stabilized by BHMT, establishing a physical interaction with its paralog as a determinant of protein stability.

   Evidence Co-transfection in COS-1 cells, co-immunoprecipitation, reticulocyte lysate degradation assay

   PMID:18457970

   Open questions at the time

   • Single lab, no reciprocal IP or stoichiometry of the BHMT/BHMT2 complex
   • Degradation pathway and ubiquitin involvement unknown
4. 2009 High

   The physiological consequence of BHMT2 activity was tied to hepatoprotection: through SMM it influences methionine and glutathione biosynthesis to limit acetaminophen toxicity, with the effect gated by dietary SMM availability.

   Evidence Multi-strain mouse genetic analysis with NMR metabolomics and in vivo dietary manipulation

   PMID:19923254

   Open questions at the time

   • Direct enzymatic step in vivo inferred rather than measured
   • Human dietary relevance not tested
5. 2010 Medium

   Substrate-specificity boundaries were refined by testing AdoMet diastereomers, showing BHMT2-containing liver extracts handle (S,S)-AdoMet but do not metabolize the age-damaged (R,S)-AdoMet.

   Evidence In vitro assay with mouse liver extracts and diastereomer substrate testing

   PMID:20370499

   Open questions at the time

   • Used crude extracts, not purified BHMT2
   • Negative result does not pinpoint the responsible enzyme
6. 2019 Medium

   Whether BHMT2 can compensate for BHMT loss was addressed by showing its transcriptional upregulation in cochlea of Bhmt knockout mice after noise damage, implicating a backup role in tissue methionine metabolism.

   Evidence Bhmt knockout mouse, cochlear qRT-PCR and RNA arrays

   PMID:30753104

   Open questions at the time

   • Compensation inferred from mRNA only, not protein or activity
   • Functional rescue not demonstrated
7. 2015 Medium

   Transcriptional control of the SMM/one-carbon module was placed under SPIC, which binds Bhmt2 enhancers and stabilizes NANOG to govern SMM-to-SAH flux and histone methylation in embryonic stem cells.

   Evidence ChIP-seq with gain/loss-of-function and metabolic flux analysis in mouse ESCs

   PMID:37595034

   Open questions at the time

   • Direct contribution of BHMT2 versus co-regulated Bhmt/Dmgdh not separated
   • Mechanism in differentiated tissues unknown
8. 2025 Medium

   An immunometabolic role was established: in intestinal epithelial cells BHMT2 with MAT1A controls AHSG via SAM and histone methylation, and BHMT2 levels bidirectionally set M1 macrophage polarization and inflammatory output.

   Evidence siRNA/overexpression in primary intestinal epithelial cells, transwell co-culture with macrophages, ChIP, and NEC mouse model

   PMID:41219226

   Open questions at the time

   • Single lab; causal chain from BHMT2 enzymatic activity to histone marks not fully reconstituted
   • Direct enzymatic versus structural contribution of BHMT2 not dissected

• It remains unresolved how BHMT2 catalysis is structurally organized and how its SMM-derived methyl flux is mechanistically linked to the SAM/histone-methylation signaling roles emerging in stem cells and immune contexts.
• No experimental structure of BHMT2
• No defined regulatory mechanism connecting metabolic activity to chromatin output
• Human in vivo physiological role beyond mouse models uncharacterized